FAAH Inhibitor Trial for Adults With Tourette Syndrome

Stopped early · Phase 1 · Has a placebo group

Conditions studied: Tourette Syndrome

In brief

The purpose of this trial is to examine the safety, tolerability and feasibility in the use of a FAAH inhibitor for the treatment of adults with Tourette syndrome.

Key facts

Study ID
NCT02134080
Run by
Yale University
People needed
5
Starts
2014-05-01
Expected to finish
2017-03-01
Last updated by the study team
2018-10-29

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.